Chapter 12: Lupus nephritis.
出版信息
Kidney Int Suppl (2011). 2012 Jun;2(2):221-232. doi: 10.1038/kisup.2012.25.
Abstract
摘要
相似文献
1
Chapter 12: Lupus nephritis.第12章：狼疮性肾炎。
Kidney Int Suppl (2011). 2012 Jun;2(2):221-232. doi: 10.1038/kisup.2012.25.
2
3
Th1/Th2 balance of SLE patients with lupus nephritis.狼疮性肾炎SLE患者的Th1/Th2平衡
Rinsho Byori. 2006 Jul;54(7):706-13.
4
The multifaceted aspects of refractory lupus nephritis.
Expert Rev Clin Immunol. 2015 Feb;11(2):281-8. doi: 10.1586/1744666X.2015.990883. Epub 2014 Dec 9.
5
Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis?狼疮性肾炎：狼疮性肾炎的治疗中目前是否仍需要进行肾活检？
Clin J Am Soc Nephrol. 2013 Jan;8(1):138-45. doi: 10.2215/CJN.03400412. Epub 2012 Sep 13.
6
Recent advances in the treatment of lupus nephritis.狼疮肾炎治疗的新进展。
Clin Exp Nephrol. 2012 Apr;16(2):202-13. doi: 10.1007/s10157-011-0556-4. Epub 2011 Nov 8.
7
Nephrotic syndrome in mesangial proliferative lupus nephritis.系膜增生性狼疮性肾炎中的肾病综合征
Pediatr Int. 2007 Dec;49(6):1009-11. doi: 10.1111/j.1442-200X.2007.02459.x.
8
[Lupus nephritis treatment].[狼疮性肾炎的治疗]
Acta Med Port. 2008 May-Jun;21(3):259-72. Epub 2008 Jul 25.
9
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis.实验性抗肾小球基底膜病作为研究自发性狼疮性肾炎的工具
Clin Immunol. 2007 Aug;124(2):109-18. doi: 10.1016/j.clim.2007.05.007.
10
Current topics in childhood lupus nephritis.
Acta Paediatr Jpn. 1993 Oct;35(5):480-7. doi: 10.1111/j.1442-200x.1993.tb03093.x.
引用本文的文献
1
Deep learning model to predict lupus nephritis renal flare based on dynamic multivariable time-series data.基于动态多变量时间序列数据的狼疮肾炎肾危象预测深度学习模型。
BMJ Open. 2024 Mar 14;14(3):e071821. doi: 10.1136/bmjopen-2023-071821.
2
Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care.儿童关节炎与风湿病研究联盟注册研究中的儿童发病狼疮性肾炎：短期肾脏状况和治疗变化。
Arthritis Care Res (Hoboken). 2023 Jul;75(7):1553-1562. doi: 10.1002/acr.25002. Epub 2023 Feb 12.
3
A Long-Term follow-up Study of Lupus Nephritis in a Single Tertiary Care Centre.单中心三级医疗中心狼疮性肾炎的长期随访研究
Indian J Nephrol. 2022 Nov-Dec;32(6):595-599. doi: 10.4103/ijn.ijn_501_21. Epub 2022 Jul 16.
4
Revisited Cyclophosphamide in the Treatment of Lupus Nephritis.重新审视环磷酰胺治疗狼疮性肾炎。
Biomed Res Int. 2022 May 26;2022:8345737. doi: 10.1155/2022/8345737. eCollection 2022.
5
Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.用尿表皮生长因子、单核细胞趋化蛋白-1 或其比值预测狼疮肾炎的治疗反应和临床病理发现。
PLoS One. 2022 Mar 10;17(3):e0263778. doi: 10.1371/journal.pone.0263778. eCollection 2022.
6
Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.初发与延迟发作狼疮肾炎患者的肾脏缓解率和无复发率比较。
Int J Rheum Dis. 2021 Dec;24(12):1500-1509. doi: 10.1111/1756-185X.14228. Epub 2021 Oct 11.
7
Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis.基于乙二醇壳聚糖的载他克莫司纳米胶束疗法可改善狼疮性肾炎。
J Nanobiotechnology. 2021 Apr 17;19(1):109. doi: 10.1186/s12951-021-00857-w.
8
Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis.2019 年 EULAR/ACR 系统性红斑狼疮分类标准在经活检证实的狼疮肾炎患者队列中的表现。
Lupus Sci Med. 2021 Feb;8(1). doi: 10.1136/lupus-2020-000458.
9
Artificial intelligence and machine learning in nephropathology.肾病病理学中的人工智能与机器学习
Kidney Int. 2020 Jul;98(1):65-75. doi: 10.1016/j.kint.2020.02.027. Epub 2020 Apr 1.
10
Utilization of Biomarkers in Lupus Nephritis.生物标志物在狼疮肾炎中的应用。
Adv Chronic Kidney Dis. 2019 Sep;26(5):351-359. doi: 10.1053/j.ackd.2019.09.001.
本文引用的文献
1
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.来氟米特与吗替麦考酚酯治疗狼疮性肾炎的长期免疫抑制作用：来自 MAINTAIN 肾炎试验的结果。
Ann Rheum Dis. 2010 Dec;69(12):2083-9. doi: 10.1136/ard.2010.131995. Epub 2010 Sep 10.
2
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.环孢素 A 或静脉注射环磷酰胺治疗狼疮性肾炎：Cyclofa-Lune 研究。
Lupus. 2010 Oct;19(11):1281-9. doi: 10.1177/0961203310371155. Epub 2010 Jul 6.
3
Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?霉酚酸酯与脉冲静脉注射环磷酰胺在诱导埃及增殖性狼疮肾炎患者中的疗效比较：霉酚酸酯更优？
Clin Exp Nephrol. 2010 Jun;14(3):214-21. doi: 10.1007/s10157-010-0270-7. Epub 2010 Feb 19.
4
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE.BILAG 多中心开放性随机对照临床试验比较环孢素与硫唑嘌呤治疗重症系统性红斑狼疮。
Rheumatology (Oxford). 2010 Apr;49(4):723-32. doi: 10.1093/rheumatology/kep396. Epub 2010 Jan 16.
5
Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.抗 CD20 治疗难治性系统性红斑狼疮患者：52 例西班牙裔患者的纵向分析。
Lupus. 2010 Feb;19(2):213-9. doi: 10.1177/0961203309351541. Epub 2009 Dec 4.
6
Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.环孢素 A 治疗难治性系统性红斑狼疮的疗效和安全性：一项日常临床实践研究。
Lupus. 2010 Feb;19(2):162-9. doi: 10.1177/0961203309350320. Epub 2009 Dec 1.
7
Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.增生性狼疮肾炎复发和终末期肾病的预测因素：重点关注儿童、青少年和年轻成年人。
Clin J Am Soc Nephrol. 2009 Dec;4(12):1962-7. doi: 10.2215/CJN.00490109. Epub 2009 Oct 9.
8
Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.单纯性狼疮性膜性肾病采用糖皮质激素联合硫唑嘌呤治疗的长期预后。
Lupus. 2009 Oct;18(12):1091-5. doi: 10.1177/0961203309106602.
9
Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option.狼疮性肾炎的口服环磷酰胺治疗：一种未充分利用的治疗选择。
Clin J Am Soc Nephrol. 2009 Nov;4(11):1754-60. doi: 10.2215/CJN.02670409. Epub 2009 Sep 3.
10
Biomarkers for lupus nephritis: the quest continues.狼疮肾炎的生物标志物：探索仍在继续。
Clin J Am Soc Nephrol. 2009 Nov;4(11):1858-65. doi: 10.2215/CJN.03530509. Epub 2009 Sep 3.
Zotero 插件